Genmab — Maj 2020
-
small New trial : Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab https://www.clinicaltrials.gov/ct2/show/NCT04407442?cond=Multiple+Myeloma&sfpd_s=05%2F15%2F2020&sfpd_d=14&sel_rss=new14
-
Darvin. Jeg tror de vågner 14.05 ????
-
...it's the final countdown!
-
Måske nogen kan få lidt ud af denne slørede version...https://meetinglibrary.asco.org/record/186016/poster
-
EL - fastest googler in the west, nothing yet?
-
a bit on Amivanta https://twitter.com/jamienholloway/status/1266352477315772419
-
-
Det kræver adgang til Asco Meeting Library for at se posters og videoer. Formoder at der dog dukker noget op på Twitter snart.
-
-
Der er smæk på og der meldes langsom loading.
-
ASCO
@ASCO
·
35 min
#ASCO20: We're aware of slow loading times on the website due to extremely high traffic. We're working to promptly resolve. Thanks for your patience! -
Initial abstracts were a bit better..
-
chosen dose for phase II 48mg
-
DLBCL complete response 21.4%, was 44% in initial abstracts
-
at data cut there was only treatment with 12mg, there is room for big improvement because chosen dose for phase II is 48mg
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind